Abstract
Gastric ulcer is positively, and duodenal ulcer negatively, associated with the risk of gastric cancer. The relationship between a common p53 polymorphism at codon 72 and gastric cancer risk in patients with gastric and duodenal ulcer was examined in 397 Caucasian patients using PCR-RFLP. Noncardiac cancer patients had a distribution pattern of codon 72 genotypes similar to that of other non-cancer patient groups, though the frequency of the Pro/Pro genotype looks higher in duodenal ulcer. However, patients with cancer of the cardiac region had a significantly higher frequency of the Arg/Arg genotype than patients with chronic gastritis, duodenal ulcer, and noncardiac cancer. There was no significant difference in the distribution patterns between gastric ulcer and noncardiac or cardiac cancer or between gastric and duodenal ulcer. These findings may be a reflection of differences in the interaction between p53 codon 72 polymorphism and local factors in the stomach.
Similar content being viewed by others
REFERENCES
Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, Fraumeni JF, Adami HO: The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 335: 242-249, 1996
Lewis JH, Woods M: Gastric carcinoma in patients with unoperated duodenal duodenal ulcer disease. Am J Gastroentrrol 77: 368-373, 1982
Norfleet RG, Johnson SE: Strange bedfellows: duodenal ulcer and cancer of the stomach. J Clin Gastroenterol 11: 382-385, 1989
Meister H, Holubarsch C, Haferkamp O, Schlag P, Herfarth C: Gastritis, intestinal metaplasia and dysplasia versus benign ulcer in stomach and duodenum and gastric carcinoma–-A histotopographical study. Pathol Res Pract 164: 259-269, 1979
Sipponen P: Update on the pathologic approach to the diagnosis of gastritis, gastric atrophy, and Helicobacter pylori and its sequelae. J Clin Gastroenterol 32: 196-202, 2001
Molloy RM, Sonnenberg A: Relation between gastric cancer and previous peptic ulcer disease. Gut 40: 247-252, 1997
Parsonnet J: Helicobacter pylori in the stomach–-A paradox unmasked. N Engl J Med 335: 278-280, 1996
Campo E, de la Calle Martin O, Miquel R, Palacin A, Romero M, Fabregat V, Vives J, Cardesa A, Yague J: Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas. Cancer Res 51: 4436-4442, 1991
Hu PJ, Li YY, Zhou MH, Chen MH, Du GG, Huang BJ, Mitchell HM, Hazell SL: Helicobacter pylori associated with a high prevalence of duodenal ulcer disease and a low prevalence of gastric cancer in a developing nation. Gut 36: 198-202, 1995
Zhang ZW, Farthing MJG: Molecular mechanisms of Helicobacter pylori associated gastric carcinogenesis. World J Gastroenterol 5: 369-374, 1999
Buchman VL, Chumakov PM, Ninkina NN, Samarina OP, Georgiev GP: A variation in the structure of the protein-coding region of the human p53 gene. Gene 70: 245-252, 1988
Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV: Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 7: 961-963, 1987
Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G: Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19: 1092-1100, 1999
Jin X, Wu X, Roth JA, Amos CI, King TM, Branch C, Honn SE, Spitz MR: Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis 16: 2205-2208, 1995
Wang YC, Chen CY, Chen SK, Chang YY, Lin P: P53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin Cancer Res 5: 129-134, 1999
Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S: Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis 14: 1085-1089, 1993
Fan R, Wu MT, Miller D, Wain JC, Kelsey KT, Wiencke JK, Christiani DC: The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 9: 1037-1042, 2000
Murata M, Tagawa M, Kimura M, Watanabe S, Saisho H: Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. Carcinogenesis 17: 261-264, 1996
Sjalander A, Birgander R, Hallmans G, Cajander S, Lenner P, Athlin L, Beckman G, Beckman L: P53 polymorphisms and haplotypes in breast cancer. Carcinogenesis 17: 1313-1316, 1996
Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L: Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393: 229-234, 1998
Tenti P, Vesentini N, Rondo Spaudo M, Zappatore R, Migliora P, Carnevali L, Ranzani GN: p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy. Cancer Epidemiol Biomarkers Prev 9: 435-438, 2000
Price AB: The Sydney System: histological division. J Gastroenterol Hepatol 6: 209-222, 1991
Zhang ZW, Newcomb PV, Hollowood AD, Feakins R, Moorghen M, Storey A, Farthing MJG, Alderson D, Holly JM: Age-associated increase of codon 72 arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma. Clin Cancer Res 9: 2151-2156, 2003
Kim DY, Baek JY: The comparison of histologic gastritis in patients with duodenal ulcer, chronic gastritis, gastric ulcer and gastric cancer. Yonsei Med J 40: 14-19, 1999
Kekki M, Sipponen P, Siurala M, Laszewicz W: Peptic ulcer and chronic gastritis: their relation to age and sex, and to location of ulcer and gastritis. Gastroenterol Clin Biol 14: 217-223, 1990
Zhang ZW, Farthing MJG: Helicobacter pylori in gastric malignancy: role of oxidants, antioxidants and other co-factors. In Hunt RH, Tytgat GNJ (eds). Helicobacter pylori: Basic Mechanisms to Clinical Cure 2000. Dordrecht/Boston/London, Kluwer Academic, 2000
Zhang ZW, Patchett SE, Perrett D, Katelaris PH, Domizio P, Farthing MJG: The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach. Gut 43: 322-326, 1998
Bevan S, Houlston RS: Genetic predisposition to gastric cancer. QJM 92: 5-10, 1999
Machado JC, Pharoah P, Sousa S, Carvalho R, Oliverira C, Figueiredo C, Amorim A, Seruca R, Caldas C, Carneiro F, Sobrinho-Simoes M: Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121: 823-829, 2001
Hiyama T, Tanaka S, Kitadai Y, Ito M, Sumii M, Yoshihara M, Shimamoto F, Haruma K, Chayama K: p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. Int J Cancer 100: 304-308, 2002
Shepherd T, Tolbert D, Benedetti J, Macdonald J, Stemmermann G, Wiest J, DeVoe G, Miller MA, Wang J, Noffsinger A, Fenoglio-Preiser C: Alterations in exon 4 of the p53 gene in gastric carcinoma. Gastroenterology 118: 1039-1044, 2000
Marin MC, Jost CA, Brooks LA, Irwin MS, O'Nions J, Tidy JA, James N, McGregor JM, Harwood CA, Yulug IG, Vousden KH, Allday MJ, Gusterson B, Ikawa S, Hinds PW, Crook T, Kaelin WG: A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet 25: 47-54, 2000
Zhang ZW, Patchett SE, Farthing MJG: The roles of Helicobacter pylori and p53 on the regulation of gastric epithelial cell cycle phase distribution. Dig Dis Sci 47: 987-995, 2002
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zhang, ZW., Newcomb, P., Hollowood, A. et al. A Comparison Study of Gastric Cancer Risk in Patients with Duodenal and Gastric Ulcer: Roles of Gastric Mucosal Histology and p53 Codon 72 Polymorphism. Dig Dis Sci 49, 254–259 (2004). https://doi.org/10.1023/B:DDAS.0000017447.02220.f5
Issue Date:
DOI: https://doi.org/10.1023/B:DDAS.0000017447.02220.f5